๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Viatris Limited โ€” Licensed Medicines

194 medicines held by Viatris Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 194 products held by Viatris Limited
MedicineActive substanceLicence holderStatus
Linagliptin Viatris 5 mg film-coated tablets
PA23266/013/001
Linagliptin Viatris Limited Not marketed
Lopinavir/Ritonavir Viatris 100 mg/25 mg film-coated tablets
EU/1/15/1067/001-003
Lopinavir, Ritonavir Viatris Limited โ€”
Lopinavir/Ritonavir Viatris 200 mg/50 mg film-coated tablets
EU/1/15/1067/004-008
Lopinavir, Ritonavir Viatris Limited โ€”
Montelukast Viatris 10 mg film-coated tablets
PA23266/025/001
Montelukast Viatris Limited Marketed
Montelukast Viatris 4 mg Chewable Tablets
PA23266/022/001
Montelukast Viatris Limited Not marketed
Montelukast Viatris 5 mg Chewable Tablets
PA23266/022/002
Montelukast Viatris Limited Not marketed
Mysildecard 20 mg film-coated tablets
EU/1/16/1134/001-003
Sildenafil citrate Viatris Limited โ€”
Nailderm 250 mg tablets
PA23266/037/001
Terbinafine Viatris Limited Marketed
Nintedanib Viatris 100 mg soft capsules
EU/1/25/1959/001-002
Nintedanib esylate Viatris Limited โ€”
Nintedanib Viatris 150 mg soft capsules
EU/1/25/1959/003-004
Nintedanib esylate Viatris Limited โ€”
Olmesartan medoxomil 10 mg film-coated tablets
PA23266/078/001
Olmesartan medoxomil Viatris Limited Not marketed
Olmesartan medoxomil 20 mg film-coated tablets
PA23266/078/002
Olmesartan medoxomil Viatris Limited Not marketed
Olmesartan medoxomil 40 mg film-coated tablets
PA23266/078/003
Olmesartan medoxomil Viatris Limited Not marketed
Olmesartan/Amlodipine Viatris 20 mg/5 mg film coated tablets
PA23266/028/001
Olmesartan medoxomil, Amlodpine besilate Viatris Limited Marketed
Olmesartan/Amlodipine Viatris 40 mg/10 mg film coated tablets
PA23266/028/003
Olmesartan medoxomil, Amlodpine besilate Viatris Limited Marketed
Olmesartan/Amlodipine Viatris 40 mg/5 mg film coated tablets
PA23266/028/002
Olmesartan medoxomil, Amlodpine besilate Viatris Limited Marketed
Omeprazole 10 mg Gastro-resistant Capsules, hard
PA23266/077/001
Omeprazole Viatris Limited Not marketed
Omeprazole 20 mg Gastro-resistant Capsules, hard
PA23266/077/002
Omeprazole Viatris Limited Not marketed
Omeprazole 40 mg Gastro-resistant Capsules, hard
PA23266/077/003
Omeprazole Viatris Limited Not marketed
Ondansetron 2 mg/ml Solution for Injection or Infusion
PA23266/040/001
Ondansetron Viatris Limited Marketed
Pemetrexed Viatris 25 mg/ml concentrate for solution for infusion
PA23266/068/001
Pemetrexed Viatris Limited Not marketed
Piperacillin Tazobactam 2 g/0.25 g powder for solution for infusion
PA23266/021/001
Piperacillin sodium, Tazobactam (as sodium salt) Viatris Limited Marketed
Piperacillin Tazobactam 4 g/0.5 g powder for solution for infusion
PA23266/021/002
Piperacillin sodium, Tazobactam (as sodium salt) Viatris Limited Marketed
Pirfenidone Viatris 267 mg film-coated tablets
EU/1/22/1707/001-007
Pirfenidone Viatris Limited โ€”
Pirfenidone Viatris 534 mg film-coated tablets
EU/1/22/1707/008-010
Pirfenidone Viatris Limited โ€”
Pirfenidone Viatris 801 mg film-coated tablets
EU/1/22/1707/011-015
Pirfenidone Viatris Limited โ€”
Pomalidomide Viatris 1 mg hard capsules
EU/1/23/1785/001-004
Pomalidomide Viatris Limited โ€”
Pomalidomide Viatris 2 mg hard capsules
EU/1/23/1785/005-008
Pomalidomide Viatris Limited โ€”
Pomalidomide Viatris 3 mg hard capsules
EU/1/23/1785/009-012
Pomalidomide Viatris Limited โ€”
Pomalidomide Viatris 4 mg hard capsules
EU/1/23/1785/013-016
Pomalidomide Viatris Limited โ€”
Posaconazole Viatris 100 mg gastro-resistant tablets
PA23266/030/001
Posaconazole Viatris Limited Marketed
Pravastatin Viatris 10 mg Tablets
PA23266/026/001
Pravastatin sodium Viatris Limited Not marketed
Pravastatin Viatris 20 mg Tablets
PA23266/026/002
Pravastatin sodium Viatris Limited Not marketed
Pravastatin Viatris 40 mg Tablets
PA23266/026/003
Pravastatin sodium Viatris Limited Not marketed
Pregabalin Mylan 100 mg hard capsules
EU/1/15/997/023-027
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 150 mg hard capsules
EU/1/15/997/028-034
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 200 mg hard capsules
EU/1/15/997/035-039
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 225 mg hard capsules
EU/1/15/997/040-044
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 25 mg hard capsules
EU/1/15/997/001-008
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 300 mg hard capsules
EU/1/15/997/045-050
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 50 mg hard capsules
EU/1/15/997/009-015
Pregabalin Viatris Limited โ€”
Pregabalin Mylan 75 mg hard capsules
EU/1/15/997/016-022
Pregabalin Viatris Limited โ€”
Rasagiline Mylan 1 mg tablets
EU/1/16/1090/001-012
Rasagiline Viatris Limited โ€”
Razolager 15 mg hard gastro-resistant capsules
PA23266/074/001
Lansoprazole Viatris Limited Not marketed
Razolager 30 mg hard gastro-resistant capsules
PA23266/074/002
Lansoprazole Viatris Limited Not marketed
Ritonavir Viatris 100 mg Film-coated tablet
EU/1/17/1242/001-003
Ritonavir Viatris Limited โ€”
Rivaroxaban Viatris 10 mg film-coated tablets
EU/1/21/1588/015-025
Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 15 mg film-coated tablets
EU/1/21/1588/026-040
Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 15 mg film-coated tablets Rivaroxaban Viatris 20 mg film-coated tablets
EU/1/21/1588/055
Rivaroxaban, Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 2.5 mg film-coated tablets
EU/1/21/1588/001-014
Rivaroxaban Viatris Limited โ€”
โ† 1 2 3 4 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.